Navigation Links
UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age

ur video EEG performed at baseline and at the end of the evaluation period with seizures identified and recorded by a central reader.

Fifty million people worldwide have epilepsy[2]. Childhood epilepsy is among the most prevalent neurological conditions. The effects of epilepsy on a child's psychological and social development are complex and cover all dimensions of a child's life and future.

Peter Verdru, Vice President, CNS Clinical Development, UCB said, 'This is the second double-blind, randomized, placebo-controlled trial of Keppra® in children, with studies in partial onset seizures now extending from infancy through adulthood.' He continued, 'This trial was designed and conducted in close collaboration with the regulatory authorities. On the basis of these positive results in younger patients with treatment resistant partial seizures we intend to file a supplementary new drug application for Keppra®'.

About Keppra® in the US[3],[4] Keppra® tablets and oral solution are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy, as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy, and as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy (IGE). Keppra® tablets and oral solution are associated with the occurrence of central nervous system adverse events including somnolence and fatigue, co-ordination difficulties and behavioral abnormalities as well as hematological abnormalities. In adults experiencing partial onset seizures, the most common adverse events associated with Keppra® in combination with other antiepileptic drugs (AEDs) were somnolence, asthenia, infection and dizziness. In pediatric patients 4-16 years of age experiencing
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... Kalifornien, und KOPENHAGEN, Dänemark, 30. Juni 2015 ... ein Weltmarktführer der klinischen und kommerziellen Produktion ... gab heute bekannt, dass das Unternehmen im ... Ausbau der nordamerikanischen Produktionsanlage in ... einer Einweg-Anlage Bioreactor 6Pack™ komplettiert hat. Die ...
(Date:6/30/2015)... , June 30, 2015  Marken, the leading clinical ... life sciences industry, has been granted permission by the ... of clinical drug product in Korea.  This precedent-setting shipment ... to continue receiving their clinical trial drugs ... The emergency was caused by recent partial ...
Breaking Medicine Technology:First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
... SAN FRANCISCO, May 6 Medizone (Pink Sheets: ... the first in a series of trials designed ... System can rapidly eliminate hospital-based bacterial pathogens known ... deaths and serious infections currently plaguing the healthcare ...
... BioTechnologies, Inc. (TriLink), a leading provider of custom ... Start PCR reagent - CleanAmp(TM) dNTPs.CleanAmp(TM) dNTPs offer ... PCR results. Using CleanAmp(TM) dNTPs allows precise ... by blocking DNA polymerase nucleotide incorporation until heat ...
Cached Medicine Technology:Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun 2
(Date:6/30/2015)... ... ... Trenton Health Team has been certified by the New Jersey Department of ... State, serving the greater Trenton community. The ACO pilot is for a three-year ... collaborative structure of THT, bringing together the vast majority of Trenton’s primary and specialty ...
(Date:6/30/2015)... , ... June 30, 2015 , ... The American Lung ... at a media event in San Diego. Speakers and clean air advocates included San ... medicine, Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... a $3.1 million grant to study how sensory stimuli can be used to “decrease ... on improving care for children with autism, will compare patient experience in a “typical ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... eyeglasses online , finally its here, http://www.express-glasses.com is proud ... rates, for many location, ask about shipping with DHL Express when calling or ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading ... management team and added a new CEO, Mr. Darold Francis. The changes will help ... premium essential oils that customers have come to know and respect for over eight ...
Breaking Medicine News(10 mins):Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2
... order to promote awareness of the issue and gain support for ... is conducting a national Health Care Day of Service on Saturday, ... host a booth at the Royal Oak Farmers, Market this Saturday ... , , They will distribute literature and applications and provide ...
... innovative oncology intelligence platform, today announced the results ... immediately following this month,s annual meeting of the ... Florida. Based on patient volume, clinical focus and ... of 43,000 cancer treaters were selected for participation ...
... June 24, 2009 Furthering its mission to ... Pharmacopeial (USP) Convention has signed a cooperative agreement ... Southeast Asian Nations (ASEAN). In a drive to ... quality control laboratories, officials from Cambodia, Laos, Myanmar, ...
... ... systems and expertise in implementing electronic patient reported outcomes (ePRO) in clinical trials, assisTek,s ... in EPC Data Management & IT Solutions. , ... Scottsdale, AZ (PRWEB) June 24, 2009 -- As a ...
... Physician Wellness Services , a company that helps ... other mental and behavioral issues that can lead to ... M.D., M.B.A., as medical director. Dr. Rosenstein will provide ... with him more than a decade of experience researching ...
... more dangerous than other routine surgeries , WEDNESDAY, June ... the largest studies on bariatric surgery find the procedure ... other studies confirm that it also appears to stave ... Duke University Medical Center analyzed data from nearly 58,000 ...
Cached Medicine News:Health News:MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 2Health News:MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 3Health News:MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 4Health News:Goal of good quality medicines advanced by new USP agreement with 9 ASEAN countries 2Health News:Journal Publishes AssisTek Article on Best Practices in Electronic Patient Reported Outcomes (ePRO) 2Health News:Physician Wellness Services Names Alan Rosenstein, M.D., M.B.A. as Medical Director 2Health News:Physician Wellness Services Names Alan Rosenstein, M.D., M.B.A. as Medical Director 3Health News:Weight-Loss Surgery Safe, Effective Type 2 Diabetes Treatment 2Health News:Weight-Loss Surgery Safe, Effective Type 2 Diabetes Treatment 3
... The MicroAire® Hi Speed Pulse Lavage ... bone surfaces as well as cleansing ... Now a great system just got ... effective with the addition of ...
... Staple is a novel shape memory alloy bone ... of its Nitinol construction, the prongs of the ... upon application of a heating current. This results ... response of bone and cause adjustable compression across ...
... deformity of the ankle joint with ... fusion of the ankle joint, fractures ... where reconstruction is impossible, and fracture/dislocations ... severe arthritic changes and loss of ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
Medicine Products: